Premium
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing... Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.24 | -5.15021459227 | 4.66 | 5 | 4.42 | 57441 | 4.79721324 | CS |
| 4 | 0.44 | 11.0552763819 | 3.98 | 5 | 3.4313 | 97296 | 4.29912951 | CS |
| 12 | -4.05 | -47.8158205431 | 8.47 | 9.6999 | 3.39 | 73970 | 4.9904758 | CS |
| 26 | -5.08 | -53.4736842105 | 9.5 | 11.23 | 3.39 | 82866 | 6.71890168 | CS |
| 52 | -6.49 | -59.4867094409 | 10.91 | 16 | 3.39 | 59019 | 8.0278641 | CS |
| 156 | -98.324 | -95.698045628 | 102.744 | 1711.2 | 3.39 | 7865716 | 34.41130724 | CS |
| 260 | -684.38 | -99.3583042973 | 688.8 | 1711.2 | 3.39 | 6295662 | 39.25233973 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
